Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
One study suggested that modifiable factors could improve racial disparities in the stage at which lung cancer is diagnosed.
More than one-third of tumors sequenced carried a high mutation burden.
Enrollment rates varied widely by study type and institution.
Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Contracting with outside firms to handle medical billing can be a smart financial move for some medical practices.
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Only 3% of medical oncologists in the United States are Black.
Most patients with solid tumors demonstrate immune responses to COVID-19 vaccines, but a subset of patients do not.
Experts outline benefits and detriments of COVID-19 vaccine mandates.
Lymphoma patients displayed cognitive decline 6 months after chemotherapy, both by objective assessment and self-report.
Responses varied according to patients’ cancer type, the anticancer treatment they received, and which vaccine was used.
The language in a patient’s medical record can convey information not only about the patient’s condition but about the attitude of the clinician writing the report.
A nanoparticle-radiotherapy regimen and a chemoimmunotherapy regimen both appear safe and effective for this population.